Serum N1-methylnicotinamide is Associated with Left Ventricular Systolic Dysfunction in Chinese

Serum N 1 ‐Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients

(2017) Ming Liu et al.   Journal of the American Heart Association

Normalization of NAD+Redox Balance as a Therapy for Heart FailureClinical Perspective

(2016) Chi Fung Lee et al.   CIRCULATION

SerumN1-Methylnicotinamide Is Associated With Obesity and Diabetes in Chinese

(2015) Ming Liu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The war against heart failure: the Lancet lecture

(2015) Eugene Braunwald   LANCET

Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity

(2014) Daniel Kraus et al.   NATURE

Obesity and Severe Obesity Forecasts Through 2030

(2012) Eric A. Finkelstein et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Urinary ketone is associated with the heart failure severity

(2012) Ji Hyung Chung et al.   CLINICAL BIOCHEMISTRY

Forecasting the Future of Cardiovascular Disease in the United States

(2011) Paul A. Heidenreich et al.   CIRCULATION

1H nuclear magnetic resonance based metabolic urinary profiling of patients with ischemic heart failure

(2010) Seok-Min Kang et al.   CLINICAL BIOCHEMISTRY

Myocardial Fatty Acid Metabolism in Health and Disease

(2010) Gary D. Lopaschuk et al.   PHYSIOLOGICAL REVIEWS

Anti-inflammatory effect of 1-methylnicotinamide in contact hypersensitivity to oxazolone in mice; involvement of prostacyclin

(2007) Krzysztof Bryniarski et al.   EUROPEAN JOURNAL OF PHARMACOLOGY